As shown in Figure 4C, the expanded alloTregs from CKD patients and healthy individuals maintained their ability to inhibit the alloantigen-specific proliferation of CD4+ (left) and CD8+ (right) T cells under all inflammatory conditions used. The gene discussed is CD8A; the disease is chronic kidney disease.